A phase II study of thalidomide and temozolomide in patients with brain metastases from malignant melanoma: lymphopenia correlates with response. - Vestermark, L. W.; Holtved, E.; Dahlrot, R.; Brimnes, M. K.; Svane, I M.; Bastholt, L. (Ecancermedicalscience, 2008)